Citation 115316

MIYATA,S: HASHIMOTO,M: FUJIE,K: SHOUHO,M: SOGABE,K: KIYOTO,S: OKUHARA,M: KOHSAKA,M:. (1992). WS009 A AND B, NEW ENDOTHELIN RECEPTOR ANTAGONISTS ISOLATED FROM STREPTOMYCES SP.NO.89009. II. BIOLOGICAL CHARACTERIZATION OF WS009 A AND B.. 45(7)

Citation Details

Title	WS009 A AND B, NEW ENDOTHELIN RECEPTOR ANTAGONISTS ISOLATED FROM STREPTOMYCES SP.NO.89009. II. BIOLOGICAL CHARACTERIZATION OF WS009 A AND B.
Authors	MIYATA,S: HASHIMOTO,M: FUJIE,K: SHOUHO,M: SOGABE,K: KIYOTO,S: OKUHARA,M: KOHSAKA,M:
Year	1992
Volume	45
Issue	7

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
2	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
3	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
4	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
5	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
6	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
7	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
8	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
9	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
10	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
11	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
12	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
13	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
14	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
15	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
16	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
17	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
18	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
19	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	INACTIVE
20	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
21	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
22	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
23	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
24	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
25	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	INACTIVE
26	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
27	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
28	SMOOTH MUSCLE RELAXANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
29	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
30	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
31	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
32	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
33	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
34	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
35	INOSITOL PHOSPHATE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE
36	ANTIHYPERTENSIVE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	STREPTOMYCES ANTIBIOTIC WS-009-A	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SMOOTH MUSCLE RELAXANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-B	ACTIVE
2	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-B	ACTIVE
3	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-B	ACTIVE
4	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-B	ACTIVE
5	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-B	ACTIVE
6	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-B	ACTIVE
7	RECEPTOR BINDING(ENDOTHELIAL) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC WS-009-B	ACTIVE

Citation 115316

Citation Details

Summary

Organisms and Their Experiments (2)

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1